Vergoeding 2018-2022 voor ATC-subgroep J05AR22 : Emtricitabine tenofoviralafenamide darunavir cobicistat
- Raming voor de totale Zvw-populatie
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
J05AR22 Emtricitabine tenofoviralafenamide darunavir cobicistat (
Symtuza ®)
|
5.658.900 | 10.280.400 | 11.410.700 | 10.965.300 | 11.625.000 |
Totaal | 5.658.900 | 10.280.400 | 11.410.700 | 10.965.300 | 11.625.000 |